<scp>ISPAD</scp> Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes
Eda Cengiz, Thomas Danne, Tariq Ahmad, Ahila Ayyavoo, David Beran, Sarah Ehtisham, Jan Fairchild, Przemysława Jarosz‐Chobot, Sze May Ng, Megan Paterson, Ethel Codner
Abstract
E. Cengiz is a scientific advisor for Eli Lilly, Novo Nordisk, Adocia and Arecor. TD has received speaker's honoraria and research support from or has consulted for Astra Zeneca, Bayer, Boehringer, Dexcom, Eli Lilly, Lifescan, Medtronic, Novo Nordisk, Provention Bio, Roche, Sanofi, Ypsomed and is a shareholder of Drea Med Ltd. TA, JF, DB, SH, MP, E. Codner have no disclosures.
Topics & Concepts
MedicineInsulin deliveryFamily medicineClinical PracticeDiabetes treatmentDiabetes mellitusInternal medicinePediatricsEndocrinologyType 1 diabetesType 2 diabetesDiabetes Management and ResearchPancreatic function and diabetesDiabetes and associated disorders